Share This
  • Dec 13, 2019

JHU-Tufts Trial Innovation Center now accepting Design Lab proposals

The JHU-Tufts Trial Innovation Center is looking for investigators who are interested in pursuing innovative clinical trial designs to participate in a Design Lab. The Design Lab, jointly run by the Tufts Institute for Clinical Research and Health Policy Studies and the MIT Center for Biomedical Innovation, will explore innovations in clinical trial design in the context of the full treatment development pathway, with a particular focus on innovative clinical effectiveness trial design. Two examples of innovative designs explored in recent Design Labs include efficacy-to-effectiveness (E2E) trials and efficacy and effectiveness too (EE2) trials, as outlined below.

Efficacy-to-Effectiveness (E2E) Trials

Innovative trials that begin with an efficacy trial, which tests how a treatment works under ideal conditions, and then seamlessly transitions to an effectiveness trial, which tests how the treatment works in usual care settings, by expanding eligibility and endpoints while the drug is under regulatory review.

Efficacy and Effectiveness Too (EE2) Trials
Innovative trials that incorporate both efficacy and effectiveness trials into a single trial, with a study sample that includes a cohort to address efficacy as well as a wider range of patients.  

The Design Lab: The purpose of the Design Lab is to explore approaches to clinical effectiveness evidence development, with a focus on different stakeholders, including patients, payers, regulators, healthcare providers and others. The Design Labs are organized according to the needs of the project being discussed. The Lab may be a half or full day session that involves a presentation by the investigator and team, and a robust discussion by a diverse multi-stakeholder group of participants.

Presentations: Investigators will develop a briefing book that outlines their proposed project, with input from Tufts and MIT. The book will be distributed to Design Lab attendees, under confidentiality agreements if required. They should include:

  1. the traditional development and marketing plan with expected outcomes and metrics, as well as
  2. a non-traditional scenario with the same metrics and a comparison of expected outcomes between the two scenarios.

Important Dates:

  • Application form returned by January 30th, 2020
  • Selection on February 6th, 2020
  • Design Lab on June 29th and 30th, 2020

Application: Please complete the application form, limiting your response to two pages (excluding appendices), save your responses as a .pdf, and submit them to Marisha Palm at no later than 5pm EST on January 30th, 2020.

Related News

GHUCCTS breaks down "The Added Value of Partnerships in Research" in recent webinar

Feb 14, 2020

GHUCCTS recently hosted a free online webinar titled "The Added Value of Partnerships in Research: Effectively Engaging Communities and Patients". This webinar is now available online.

Funding Opportunity: ACCOuNT TCC now accepting pilot grant applications

Jan 22, 2020

The African American Pharmacogenomic Consortium Network Transdisciplinary Collaborative Center (ACCOuNT TCC) – a partnership between ITM investigators and Northwestern University – is offering a Pilot Grant Program to stimulate community stakeholders to be the principal drivers of pharmacogenomics-enabling research projects that they conceive, plan, and execute with support from research collaborators.

Register Today: GHUCCTS Responsible Conduct of Research Training

Jan 17, 2020

GHUCCTS is offering face-to-face training for predoctoral students, postdoctoral fellows and early career investigators in the responsible conduct of research in order to promote ethical, rigorous and reproducible science. The series dovetails to required CITI modules and provides an opportunity for investigators to discuss all aspects of these topics with an expert in the field. This series also fulfills the requirements of multiple funding agencies.